Skip to main content
NVDA0.00%AAPL+0.19%GOOGL-2.28%MSFT+0.03%AMZN+0.05%TSM-0.83%SPCX-3.86%AVGO-1.13%META-0.28%TSLA-0.08%SKHY+7.05%MU-0.17%BRK-B+0.18%LLY+0.03%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.95%JNJ-0.76%INTC+1.69%0700.HK-0.32%MA-0.59%ORCL-0.55%1398.HK+0.53%BAC+0.45%ABBV+0.86%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.00%0005.HK+0.67%HSBA.L-1.63%DELL+0.29%UNH-1.94%MS-0.42%PG-2.02%GE-2.83%0857.HK+0.77%1816.HK-0.23%3988.HK+0.68%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+0.52%NZDJPY-2.44%CHFJPY-1.74%USDJPY-1.73%EURJPY-1.54%AUDJPY-1.53%CADJPY-1.50%GBPJPY-1.45%GBPNZD+0.98%NZDCAD-0.96%EURNZD+0.94%AUDNZD+0.94%NZDUSD-0.73%NZDCHF-0.70%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%GBPUSD+0.26%CADCHF+0.24%GBPCHF+0.23%USDCAD-0.22%AUDUSD+0.20%EURUSD+0.20%AUDCHF+0.20%USDILS+0.16%EURCHF+0.13%USDTRY+0.11%USDTHB+0.07%AUDCAD-0.04%USDCOP-0.04%EURCAD-0.03%EURGBP-0.03%USDCHF-0.03%USDCNH-0.02%GBPCAD+0.02%USDHKD+0.02%EURAUD-0.01%GBPAUD0.00%USDNOK0.00%EURSEK0.00%GBPSGD0.00%GBPZAR0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDMXN0.00%EURNOK0.00%NZDSGD0.00%EURCZK0.00%SGDJPY0.00%NOKJPY0.00%AUDSGD0.00%USDMXN0.00%EURDKK0.00%USDSEK0.00%USDZAR0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%USDDKK0.00%USDPLN0.00%AUDDKK0.00%CHFSGD0.00%CHFSEK0.00%USDSGD0.00%GAGUSD0.00%HG10.00%S10.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%C10.00%XNGUSD0.00%COCOA0.00%COFFEE0.00%COTTON0.00%BTCUSD-0.30%ETHUSD-0.68%USDTUSD-0.03%XRPUSD-1.16%SOLUSD-0.98%TRXUSDT+0.06%ZECUSDT+5.64%DOGEUSD-3.60%XMRUSDT+2.25%LINKUSD-5.84%XLMUSD-2.82%BCHUSDT-1.19%LTCUSD-1.33%UNIUSD-5.77%TONUSD+22.39%HBARUSDT-2.65%SUIUSD-3.37%TAOUSDT-1.34%AAVEUSD-2.47%DOTUSDT-10.88%ICPUSDT-3.34%WLDUSDT-6.11%ONDOUSDT-2.85%ATOMUSDT-0.05%ARBUSDT-8.52%JUPUSDT-0.97%INJUSDT-5.24%STXUSDT-0.70%FETUSDT-3.92%TIAUSDT-5.17%SEIUSDT-4.14%PYTHUSDT+0.73%IMXUSDT-3.39%WIFUSDT-1.74%GRTUSDT-2.23%OPUSDT-4.54%IOTAUSDT+2.74%POLUSDT+1.05%AXSUSDT-1.49%FARTCOINUSDT-8.23%EOSUSDT-1.84%DYDXUSDT-2.16%ORDIUSDT-4.32%GALAUSDT-3.97%NOTUSDT-2.48%RONINUSDT-0.16%NVDA0.00%AAPL+0.19%GOOGL-2.28%MSFT+0.03%AMZN+0.05%TSM-0.83%SPCX-3.86%AVGO-1.13%META-0.28%TSLA-0.08%SKHY+7.05%MU-0.17%BRK-B+0.18%LLY+0.03%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.95%JNJ-0.76%INTC+1.69%0700.HK-0.32%MA-0.59%ORCL-0.55%1398.HK+0.53%BAC+0.45%ABBV+0.86%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.00%0005.HK+0.67%HSBA.L-1.63%DELL+0.29%UNH-1.94%MS-0.42%PG-2.02%GE-2.83%0857.HK+0.77%1816.HK-0.23%3988.HK+0.68%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+0.52%NZDJPY-2.44%CHFJPY-1.74%USDJPY-1.73%EURJPY-1.54%AUDJPY-1.53%CADJPY-1.50%GBPJPY-1.45%GBPNZD+0.98%NZDCAD-0.96%EURNZD+0.94%AUDNZD+0.94%NZDUSD-0.73%NZDCHF-0.70%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%GBPUSD+0.26%CADCHF+0.24%GBPCHF+0.23%USDCAD-0.22%AUDUSD+0.20%EURUSD+0.20%AUDCHF+0.20%USDILS+0.16%EURCHF+0.13%USDTRY+0.11%USDTHB+0.07%AUDCAD-0.04%USDCOP-0.04%EURCAD-0.03%EURGBP-0.03%USDCHF-0.03%USDCNH-0.02%GBPCAD+0.02%USDHKD+0.02%EURAUD-0.01%GBPAUD0.00%USDNOK0.00%EURSEK0.00%GBPSGD0.00%GBPZAR0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDMXN0.00%EURNOK0.00%NZDSGD0.00%EURCZK0.00%SGDJPY0.00%NOKJPY0.00%AUDSGD0.00%USDMXN0.00%EURDKK0.00%USDSEK0.00%USDZAR0.00%EURHKD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%USDDKK0.00%USDPLN0.00%AUDDKK0.00%CHFSGD0.00%CHFSEK0.00%USDSGD0.00%GAGUSD0.00%HG10.00%S10.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%C10.00%XNGUSD0.00%COCOA0.00%COFFEE0.00%COTTON0.00%BTCUSD-0.30%ETHUSD-0.68%USDTUSD-0.03%XRPUSD-1.16%SOLUSD-0.98%TRXUSDT+0.06%ZECUSDT+5.64%DOGEUSD-3.60%XMRUSDT+2.25%LINKUSD-5.84%XLMUSD-2.82%BCHUSDT-1.19%LTCUSD-1.33%UNIUSD-5.77%TONUSD+22.39%HBARUSDT-2.65%SUIUSD-3.37%TAOUSDT-1.34%AAVEUSD-2.47%DOTUSDT-10.88%ICPUSDT-3.34%WLDUSDT-6.11%ONDOUSDT-2.85%ATOMUSDT-0.05%ARBUSDT-8.52%JUPUSDT-0.97%INJUSDT-5.24%STXUSDT-0.70%FETUSDT-3.92%TIAUSDT-5.17%SEIUSDT-4.14%PYTHUSDT+0.73%IMXUSDT-3.39%WIFUSDT-1.74%GRTUSDT-2.23%OPUSDT-4.54%IOTAUSDT+2.74%POLUSDT+1.05%AXSUSDT-1.49%FARTCOINUSDT-8.23%EOSUSDT-1.84%DYDXUSDT-2.16%ORDIUSDT-4.32%GALAUSDT-3.97%NOTUSDT-2.48%RONINUSDT-0.16%
AN

Annexon, Inc. (ANNX)

NASDAQ • Healthcare

$4.37
-$0.29 (-6.4%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$4.63
Day Range$4.34 - $4.66
Avg. Volume (3M)2.5M
Market Cap$729M
52 Week Range
$2.1$7.18
Next EarningsIn 61 daysNov 9, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$202.6M
EPS (TTM)
-$1.16
ROA (TTM)
-82.36%
Current Ratio
5.53

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+12.5%Q1 2026-$0.28
+23.3%Q2 2026-$0.23
-17.2%Q3 2026-$0.28
Next

Nov 9

in 61 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -17.2%

Annexon’s EPS of -$0.28 trailed the -$0.24 estimate, -17%, as it reported preliminary second fiscal quarter of 2026 results on Aug. 12. Operating loss came to about $57.2 million, net income was a loss of about $55.3 million, down 12.6% from a loss of about $49.2 million a year ago, and operating cash flow was negative about $48.0 million. Consensus for the next period calls for EPS of -$0.26 on revenue of $3.5 million.

View full earnings history

About Annexon, Inc.

Annexon, Inc. is a NASDAQ-listed biotechnology company developing therapies that act on the classical complement pathway through the C1q molecule. The company focuses on autoimmune, neurodegenerative, and ophthalmic conditions, and operates as a clinical-stage business from Brisbane, California after its 2020 public listing.

Name
Annexon, Inc.
CEO
Douglas E. Love
Website
www.annexonbio.com
Industry
Healthcare
Year Founded
2011
Employees
92

Today's Snapshot

AI-generated

ANNX closed 6.4% lower at 4.37, while its sector was flat. Volume was roughly twice its usual level. Annexon presented its late-stage drug programs at a Wells Fargo healthcare conference.

Trading Volume

Above 10d avg 2.4M

5.5M

vs S&P 500 Today

Strong Underperformance

-6.00%

Updated: September 9, 2026 at 20:23 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
ANNX is technically weak, trading beneath nearly all moving averages including the long-term averages, and momentum indicators paint an oversold profile even as stochastic signals show a very short-term bounce. The CCI is deeply negative and MACD remains unfavorable, while ADX shows little directional strength, implying the downtrend lacks forceful conviction. Volatility is meaningful for the price level and ATR is material, and on-balance volume is negative, pointing to continued outflows. The pivot sits above the market and acts as nearby resistance. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$4.82 - $5.24
    Sell
  • RSI (14)31.74
    Neutral
  • Stochastic %K (14, 3, 3)6.36
    Buy
  • MACD Level (12, 26)-0.18
    Sell

Peers & Related Assets

AURAAura Biosciences, Inc.
$7.2-2.2%
ALTAltimmune, Inc.
$3.35-0.3%
LRMRLarimar Therapeutics, Inc.
$3.87-5.2%
KRROKorro Bio, Inc.
$12.93-4.3%
LBRXLB Pharmaceuticals Inc Common Stock
KYTXKyverna Therapeutics, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.